FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma

Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery

Organon and Samsung Bioepis expand Canada biosimilar partnership with PYZCHIVA

IDEAYA Biosciences names Yujiro S. Hata as new chairman

Niowave and Ratio Therapeutics agree Actinium-225 supply deal for targeted alpha therapies

Minghui Pharmaceutical presents MHB018A Phase I/II results for thyroid eye disease at ENDO 2026

Lonza and Antharis Therapeutics enter target-specific licence agreement

Inhibrx's ozekibart BLA accepted by FDA for chondrosarcoma treatment

Sensei Biotherapeutics changes name to Faeth Therapeutics

AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer

Acousia Therapeutics reports positive top-line efficacy results for ACOU085 in cisplatin-induced ototoxicity

Menarini reports Phase 3 data for selinexor plus ruxolitinib in myelofibrosis

Roche secures IVDR approval to expand VENTANA MMR RxDx Panel indications

Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS

PharmaEssentia expands North American footprint with acquisition of Canadian partner FORUS Therapeutics